QQQ $ 608.66 $ 0.00 (0 %)
DIA $ 468.02 $ 0.00 (0 %)
SPY $ 667.77 $ 0.00 (0 %)
TLT $ 89.72 $ 0.00 (0 %)
GLD $ 367.79 $ 0.00 (0 %)
$ na
-- x --
-- x --
-- - --
$ 0.02 - $ 23.82
12,716
na
2.42M
$ 2.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nyse-to-begin-delisting-proceedings-against-danimer-scientific

NYSE Regulation reached its decision to delist the Company's Class A common stock pursuant to Section 802.01B of the NYSE&#...

 danimer-scientific-q3-eps-018-beats-820-estimate-sales-863m-beat-858m-estimate

Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(8....

 danimer-scientific-announces-intention-to-complete-a-1-for-40-reverse-stock-split-expected-to-begin-trading-on-a-split-adjusted-basis-on-november-13-2024

Expected to Begin Trading on a 1-for-40 Reverse Split-Adjusted Basis on November 13, 2024Danimer Scientific, Inc. (NYSE:DNMR) (...

 danimer-scientific-announces-second-circuit-court-affirms-dismissal-of-class-action-lawsuit

Danimer Scientific, Inc. (NYSE:DNMR) ("Company" or "Danimer Scientific"), a leading next generation bioplastics...

 danimer-scientific-names-richard-altice-interim-ceo-preliminary-q3-pha-revenue-of-67m-increased-by-08m-compared-to-q2-2024-company-maintains-its-forecast-that-annualized-pha-revenues-will-more-than-triple-by-the-end-of-q2-2025

Current Board Member and Former CEO of NatureWorks to Lead Company While Board Continues Search Process for Permanent CEOCompan...

 piper-sandler-maintains-neutral-on-danimer-scientific-lowers-price-target-to-1

Piper Sandler analyst Charles Neivert maintains Danimer Scientific (NYSE:DNMR) with a Neutral and lowers the price target fr...

 td-cowen-downgrades-danimer-scientific-to-hold-lowers-price-target-to-1

TD Cowen analyst Thomas Boyes downgrades Danimer Scientific (NYSE:DNMR) from Buy to Hold and lowers the price target from $2...

 danimer-scientific-q2-2024-gaap-eps-019-beats-024-estimate-sales-7628m-miss-9270m-estimate

Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0....

 jefferies-downgrades-danimer-scientific-to-hold-lowers-price-target-to-08

Jefferies analyst Laurence Alexander downgrades Danimer Scientific (NYSE:DNMR) from Buy to Hold and lowers the price target ...

 danimer-scientifics-ceo-and-chairman-steve-croskrey-announces-retirement-to-step-down-as-ceo-no-later-than-the-end-of-this-calendar-year-to-exit-chairman-position-may-20-2024-board-appoints-richard-j-hendrix-as-interim-ceo-and-new-co-chairman

Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics compan...

 danimer-scientific-q1-2024-gaap-eps-026-beats-031-estimate-sales-10224m-miss-11063m-estimate

Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION